Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus.

MLA

Sise, Meghan E., et al. “Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus.” Hepatology Communications, vol. 4, no. 8, Aug. 2020, pp. 1206–17. EBSCOhost, https://doi.org/10.1002/hep4.1528.

APA

Sise, M. E., Strohbehn, I., Chute, D., Corey, K. E., Fusco, D. N., Sabbisetti, V. S., Waikar, S. S., & Chung, R. T. (2020). Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus. Hepatology Communications, 4(8), 1206–1217. https://doi.org/10.1002/hep4.1528

Chicago

Sise, Meghan E., Ian Strohbehn, Donald Chute, Kathleen E. Corey, Dahlene N. Fusco, Venkata S Sabbisetti, Sushrut S. Waikar, and Raymond T. Chung. 2020. “Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus.” Hepatology Communications 4 (8): 1206–17. doi:10.1002/hep4.1528.